EFFICACY STUDIES ON A CANARYPOX-RABIES RECOMBINANT VIRUS

被引：129
|
作者：
TAYLOR, J
TRIMARCHI, C
WEINBERG, R
LANGUET, B
GUILLEMIN, F
DESMETTRE, P
PAOLETTI, E
机构：
[1] VIROGENET CORP,465 JORDAN RD,RENSSELAER TECHNOL PK,TROY,NY 12180
[2] NEW YORK STATE DEPT HLTH,WADSWORTH CTR LABS & RES,ALBANY,NY 12201
[3] RHONE MERIEUX,F-69007 LYONS,FRANCE
来源：
VACCINE | 1991年 / 9卷 / 03期
关键词：
RECOMBINANT; CANARYPOX; RABIES; FOWLPOX; VACCINIA;
D O I：
10.1016/0264-410X(91)90152-V
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Recombinant avipox viruses have been developed expressing the rabies glycoprotein gene. A fowlpox-rabies recombinant has previously been shown to be protective against live rabies virus challenge in a number of non-avian species1. This report describes the development of a canarypox-rabies recombinant. A comparison is made of the protective efficacy of this recombinant with other pox-rabies recombinants.
引用
收藏
页码：190 / 193
页数：4
相关论文
共 50 条
  • [1] Three-year duration of immunity in cats vaccinated with a canarypox-vectored recombinant rabies virus vaccine
    Jas, D.
    Coupier, C.
    Toulemonde, C. Edlund
    Guigal, P-M.
    Poulet, H.
    VACCINE, 2012, 30 (49) : 6991 - 6996
  • [2] TOWARDS RABIES ELIMINATION IN BELGIUM BY FOX VACCINATION USING A VACCINIA-RABIES GLYCOPROTEIN RECOMBINANT VIRUS
    BROCHIER, B
    BOULANGER, D
    COSTY, F
    PASTORET, PP
    VACCINE, 1994, 12 (15) : 1368 - 1371
  • [3] A recombinant canarypox virus protects rabbits against a lethal rabbit hemorrhagic disease virus (RHDV) challenge
    Fischer, L
    LeGros, FX
    Mason, PW
    Paoletti, E
    VACCINE, 1997, 15 (01) : 90 - 96
  • [4] Oral vaccination of dogs with recombinant rabies virus vaccines
    Rupprecht, CE
    Hanlon, CA
    Blanton, J
    Manangan, J
    Morrill, P
    Murphy, S
    Niezgoda, M
    Orciari, LA
    Schumacher, CL
    Dietzschold, B
    VIRUS RESEARCH, 2005, 111 (01) : 101 - 105
  • [5] Safety profile of recombinant canarypox HIV vaccines
    de Bruyn, G
    Rossini, AJ
    Chiu, YL
    Holman, D
    Elizaga, ML
    Frey, SE
    Burke, D
    Evans, TG
    Corey, L
    Keefer, MC
    VACCINE, 2004, 22 (5-6) : 704 - 713
  • [6] A recombinant rabies virus (ERAGS) for use in a bait vaccine for swine
    Yang, Dong-Kun
    Kim, Ha-Hyun
    Choi, Sung-Suk
    Lee, Seong Heon
    Cho, In-Soo
    CLINICAL AND EXPERIMENTAL VACCINE RESEARCH, 2016, 5 (02) : 169 - 174
  • [7] Immunogenic and antigenic properties of recombinant soluble glycoprotein of rabies virus
    Gupta, PK
    Sharma, S
    Walunj, SS
    Chaturvedi, VK
    Raut, AA
    Patial, S
    Rai, A
    Pandey, KD
    Saini, M
    VETERINARY MICROBIOLOGY, 2005, 108 (3-4) : 207 - 214
  • [8] Prevention of rabies virus infection in dogs by a recombinant canine adenovirus type-2 encoding the rabies virus glycoprotein
    Hu, Rongliang
    Zhang, Shoufeng
    Fooks, Anthony R.
    Yuan, Huijun
    Liu, Ye
    Li, Haitao
    Tu, Changchun
    Xia, Xianzhu
    Xiao, Yueqiang
    MICROBES AND INFECTION, 2006, 8 (04) : 1090 - 1097
  • [9] FIELD TRIALS OF A RECOMBINANT RABIES VACCINE
    PASTORET, PP
    BOULANGER, D
    BROCHIER, B
    PARASITOLOGY, 1995, 110 : S37 - S42
  • [10] Recombinant rabies virus expressing dog GM-CSF is an efficacious oral rabies vaccine for dogs
    Zhou, Ming
    Wang, Lei
    Zhou, Songqin
    Wang, Zhao
    Ruan, Juncheng
    Tang, Lijun
    Jia, Ziming
    Cui, Min
    Zhao, Ling
    Fu, Zhen F.
    ONCOTARGET, 2015, 6 (36) : 38504 - 38516
12345